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SAU : Pleaseconfirmthatallheadinglevelsarerepresentedcorrectly:ummary points
• Improvements in HIV service delivery are key to bringing countries closer to achiev-
ing the target of ending AIDS as a public health threat and situating HIV treatment
and care as part of universal healthcare coverage.
• The World Health Organization (WHO) guideline development process is recognized
as one approach to identifying research gaps. Systematic reviews form the basis of rec-
ommendations formulated by an expert guideline development group, which is also
tasked to identify research gaps.
• The 2021 WHO HIV Service Delivery Guideline process identified 27 research gaps
grouped into 8 areas where more research is needed to support enhancement and
implementation of the new recommendations across the cascade of care.
• Areas covered by the WHO Service Delivery Guideline include antiretroviral therapy
(ART) initiation outside the health facility, frequency of visits/refills, tracing and reen-
gagement in care, assessing adherence, integration of HIV and sexual and reproductive
health services, integration of HIV and diabetes and hypertension care, psychosocial
interventions for adolescents, and task sharing of specimen collection and point-of-
care testing.
• Key areas identified by the guideline process that could benefit from future research
include tools to support ART initiation outside the health facility, outcomes of spacing
of clinical visits/drug refills beyond 6 months, tailored support to minimize disengage-
ment and support reengagement along the continuum of care, and accurate, feasible
measures of adherence.
• Strategies of integration of HIV and sexual and reproductive health services and
hypertension and diabetes care, costs and cost-effectiveness of psychological support
interventions, the performance of newer point-of-care technologies by nonlaboratory
personnel, and the impact of diagnostic integration across disease types were also iden-
tified as key areas that would benefit from future research.
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Introduction
In 2016, the World Health Organization (WHO) published guidelines recommending that all
people living with HIV start antiretroviral therapy (ART) irrespective of disease status. This
recommendation has been widely adopted by countries, substantially increasing the number
of individuals eligible to start treatment [1]. These 2016 guidelines also provide several recom-
mendations promoting differentiated service delivery as a way to simplify and rationalize care
delivery by reducing requirements to visit health services; recommendations supporting task
sharing, decentralization, and service integration were made with the aim of increasing access
to care while maintaining quality [2].
Since the publication of these guidelines, several important studies have provided additional
evidence to help improve ART start. In particular, accelerating the offer of ART, including on
the same day that a diagnosis is made, has been found to increase uptake of ART and viral sup-
pression [3,4]. It was recognized that an important number of patients continued to present
with advanced HIV disease, either because they were diagnosed late in their infection or
because they had disengaged from care and stopped taking treatment [5]. The results of 2 trials
supported the provision of a package of care including diagnostics or prophylactics to all
patients presenting with advanced HIV disease to reduce mortality [6]. Recommendations
supporting rapid initiation of ART and provision of a package of care for advanced HIV dis-
ease were included in a subsequent WHO guideline published in 2017 [7].
At the end of 2018, WHO convened an expert consultation to define future priorities for
HIV treatment service delivery [8]. The outcomes of this consultation provided a roadmap for
the updated HIV service delivery guidelines that were published in April 2021 [9]. The new
guidelines put forward recommendations on starting treatment outside of the health facility,
the frequency of clinic visits and drug dispensing, tracing and reengagement in care, assessing
adherence, integration of HIV and sexual and reproductive health and noncommunicable dis-
ease services, task sharing of specimen collection and point-of-care testing, and psychosocial
support for adolescents and young adults.
Systematic reviews provide the basis for the formulation of guideline recommendations
and also provide an opportunity to identify important evidence gaps to be addressed in future
guidelines. As part of a collection of articles addressing evidence to inform policy and practice
of HIV service delivery [8], this article summarizes the research gaps that were identified dur-
ing the development of these guidelines.
Identifying research gaps as part of guideline development
The WHO guideline development process is recognized as one approach to identifying
research gaps [10]. A guideline development group is convened that includes a diversity of
experts and relevant stakeholders from across all WHO regions affected by the public health
problem. Systematic reviews form the basis of formulating recommendations through an
assessment of potential benefits and harms, values and preferences, feasibility and resource use
regarding the recommended intervention [11]. Each of the areas addressed by the updated
WHO HIV Service Delivery Guidelines was informed by 1 or more systematic reviews. The
Grading of Recommendations, Assessment, Development and Evaluations (GAU : PleasenotethatGRADEhasbeendefinedasGradingofRecommendations;Assessment;DevelopmentandEvaluationsinthesentenceTheGradingofRecommendations;Assessment;DevelopmentandEvaluationsðGRADEÞframeworkisused::::Pleasecheckandcorrectifnecessary:RADE) frame-
work is used to determine the certainty of the evidence, which is a key driver of the strength of
the recommendation [12]. Five domains—risk of bias, reporting bias, imprecision, indirect-
ness, and inconsistency—are used to rate the certainty of the evidence. These domains reflect
limitations in the existing evidence, either because the evidence base is small, or comprised of
studies with contradictory findings, or studies that have important methodological flaws. For
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Assessment, Development and Evaluations; WHO,
World Health Organization.
those interventions supported by low or moderate certainty evidence, additional research
could increase the certainty of the evidence and the strength of the recommendation [13].
Guideline development groups are also tasked to formulate research gaps considering the
limitations of the evidence identified by the systematic reviews. Once drafted, the guideline is
reviewed by an external review group, which again is comprised of leading experts and rele-
vant stakeholders from across all WHO regions; this group can provide further inputs into the
research gaps that have been identified. Three types of evidence gaps are commonly identified
through this process. First, there is insufficient evidence to inform which interventions should
be recommended to address a given service delivery challenge (e.g., the most accurate way to
measure medication adherence); second, evidence exists but is insufficient to support a recom-
mendation for a specific population group (e.g., pregnant women); third, there is no evidence
from a particular setting (e.g., community settings) or geographical regions (e.g., Latin Amer-
ica), limiting the scope of implementation of a given recommendation.
The guideline development group for the WHO 2021 HIV Service Delivery Guidelines [14]
included 19 experts from 13 countries who appraised the evidence derived from 17 systematic
reviews, in addition to surveys on values and preferences of health workers and recipients of
care. The draft guidelines, including a draft set of research gaps, were reviewed by an external
review group comprising 13 experts from 10 countries. Through this process, 27 research gaps
were identified, grouped into 8 areas where more research is needed to support enhancement
and implementation of the new recommendations. These are summarized in Table 1 and
detailed below per recommendation area.
ART initiation outside the health facility
Background
Community-based HIV testing approaches are a key component of any HIV testing strategy
[15]. Rapid initiation of ART, including starting on the same day of a positive diagnosis, has
also been widely adopted in policy and practice [6]. However, there are substantial losses to
care between community HIV testing and ART initiation, with proportions linking to care as
low as 14% for home-based testing and 10% for community-based testing [16]. A study from
South Africa and Zambia found that people testing positive in the community often delayed
starting ART because of issues related to the quality of care and stigma associated with access-
ing care [17]. Other cited concerns include lack of time [18] and concern about long clinic
waiting times [19].
What was found
The recommendation to provide out of facility ART initiation was supported by evidence from
3 randomized trials and 4 observational studies carried out in sub-Saharan Africa, except for 1
study that was carried out in Haiti [20]. Offering ART initiation outside the health facility was
associated with an increase in the proportion of people starting ART, increased retention in
care at 6 to 12 months following ART initiation, and increased viral load suppression at 12
months. Only 1 study was conducted in adolescents, and overall the certainty of the evidence
was rated as low due to substantial heterogeneity in terms of effects, strategies, and populations.
Future research
Research is needed to improve understanding of client preferences about where to start ART
and how to link to and differentiate care across different age groups, populations, and settings.
Tools to support initiation outside the health facility need to be identified and evaluated. The
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identified studies showed substantial variability in the size of the community treatment teams,
and implementation research would be valuable in defining the optimum staffing complement
and minimum set of skills required. In addition, high-quality observational data collected dur-
ing implementation will help with early identification of challenges that may arise and be
addressed when community ART initiation is implemented outside of more controlled
research environments. Finally, evidence is needed on how ART initiation outside the facility
affects household spending.
Table 1. Research gaps identified during the HIV service delivery guideline development process.
Area of intervention Research gaps Evidence
ART initiation outside the health facility Client preferences about where to start ART and how to link to care by age,
population, and setting
Mixed methods
Tools to support initiation outside the health facility Quantitative (comparative
intervention)
Optimum staffing complement and minimum set of skills Health service research
Effect on household spending and catastrophic costs Economic evaluation
High-quality observational research during implementation to evaluate short and
long-term outcomes
Quantitative
Frequency of visits/refills Outcomes of spacing of clinical visits/drug refills >6 months Quantitative comparative
intervention)




Acceptability and effectiveness of approaches for tracing and reengagement by
population
Mixed methods
Assessing adherence Accurate, feasible measures of adherence Diagnostic accuracy
Integration of HIV and sexual and
reproductive health services
Approaches to integration that lead to better uptake of sexual and reproductive
health services, including contraception
Health service research
Strategies of integration in different health systems and social contexts Health service research
Provision of contraception in the context of less frequent clinical and ART refill
visits
Quantitative
Integration of HIV and diabetes and
hypertension care
Long-term data on the health outcomes of people living with HIV who have
noncommunicable diseases
Longitudinal cohort
Cost-effectiveness of various models of integrated care Economic evaluation
Supply chain optimization Health service research
Health promotion to encourage lifestyle changes among people living with HIV Quantitative (comparative
intervention)
Integration of hypertension and diabetes care with common differentiated models of
service delivery
Implementation research
Values and preferences related to care delivery Qualitative
Psychosocial interventions for adolescents
and young adults




Content and delivery strategies for interventions to involve parents and caregivers Health service research
Training, supervision, and support for facilitators of psychosocial interventions Health service research
Costs and cost-effectiveness of psychological support interventions Economic evaluation
Long-term outcomes of psychosocial interventions Longitudinal cohort
Task sharing of specimen collection and
point-of-care testing
Performance of newer point-of-care technologies by nonlaboratory personnel Diagnostic accuracy
Balanced integration of diagnostic services Impact of diagnostic integration across disease types Quantitative (comparative
intervention)
Best practices for diagnostic integration Implementation research
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Frequency of visits/refills
Background
In 2016, WHO recommended clinical visits every 3 to 6 months and dispensing ART lasting 3
to 6 months for people established on ART [7]. Two distinct recommendations were made to
underscore the point that clinical visits and medication dispensing should be considered sepa-
rately. These recommendations have been broadly adopted by national policy, but there is
uncertainty about the optimal visit/dispensing frequency.
What was found
The systematic review supporting the 2021 guidelines found 23 studies, including 8 random-
ized trials. Except for 1 study done in Haiti, all studies were conducted in sub-Saharan Africa.
Overall, there was no difference in retention in care or viral suppression comparing 3- and
6-month visit frequency or ART dispensing. There was insufficient evidence to support
extending the frequency of visits or dispensing beyond this period. Nevertheless, there are con-
texts in which annual clinical visits are the standard of care and may benefit clients and reduce
costs for health systems and outcomes associated with this approach should be assessed. Most
of the studies to date have been conducted among adults, and more evidence is needed for
children and adolescents. Evidence from a greater diversity of geographical settings would also
be valuable.
Future research
Given the range of differentiated service delivery models being considered by national HIV
treatment programs (e.g., community- and facility-based adherence clubs), the guideline
development group considered that research on the comparative effectiveness, comparative
cost-effectiveness, and comparative implementability of these models would be important to
inform policy and prioritization. The introduction of one model to existing models would be
useful to understand the additional contribution of a program to “mosaic effectiveness” [21].
Tracing and reengagement in care
Background
Losses to care remain substantial in all regions and are especially high in southern Africa,
affecting all age groups [22–24]. People are known to disengage from care for a variety of rea-
sons, and successful tracing and reengagement allows people to reinitiate ART and receive the
care they need to prevent deterioration of health status and achieve viral suppression.
What was found
The systematic review found 37 studies that assessed activities to trace individuals who have
disengaged and identified interventions to support reengagement. These studies were carried
out in Africa, the United States of America, and Australia; 8 studies included children and ado-
lescents. Approaches to tracing varied between low- and high-income countries and included
remote communication (phone, text, mail, and email), in-person tracing, and a combination
of approaches. Overall, the review found that, when asked, 58% (95% CI 51 to 65%) were will-
ing to reengage in care. Nine studies compared reengagement interventions to a control condi-
tion, and, in this analysis, reengagement interventions improved return to care compared to
standard care.
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PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003812 September 23, 2021 5 / 13
Future research
Several studies have described the most common reasons for disengagement from care either
before or after initiating ART [25–28]. Research is needed to tailor support that responds to
these drivers to minimize disengagement and support reengagement at different stages along
the continuum of care. Qualitative research is important to understand the most acceptable
and effective methods of tracing and reengagement. Future research should include disaggre-
gation of approaches based on the population group (e.g., key populations), sex, and age and
investigate approaches to facilitate return and support retention after return.
A recent systematic review of published criteria and definitions across the HIV care cascade
in sub-Saharan Africa found that proportions of individuals retained in care at each step of the
HIV care cascade cannot be compared between studies due to the highly variable definitions
used for numerators and denominators; this review concluding that there is a need for stan-
dardized methods and definitions [29]. In general, the review process of reengagement also
revealed an urgent need to standardize conceptualization and representation of the reengage-
ment cascade and how to harmonize quantification of effects. For example, when seeking to
assess a descriptive estimate of the incidence of “return” among lost patients, some studies
reported return among all patients who had a missed visit in the electronic medical record,
while other studies examined return in those who the facility tried to contact or among those
successfully contacted [30]. In addition, the amount of time elapsed between the missed visit
and when studies began to consider patients to be lost and therefore “count” their subsequent
visits as “returns to clinic,” varied from a few days to several weeks or even months, while in
other studies, this interval was not specified [31–33], again yielding estimates with fundamen-
tally different significance. Consistent nomenclature, harmonized metrics, and a transparent
description of the reengagement cascade would help to advance the science.
Assessing adherence
Background
WHO strongly recommends that adherence support interventions should be provided to peo-
ple on ART [7]. Viral load monitoring is the gold standard for monitoring adherence and con-
firming treatment response, but knowledge of adherence is important to support decisions
about whether a recipient of care is eligible for simplified models of service delivery and
whether to switch treatment regimens when viral load is unsuppressed. Simple, affordable
measures suggested by WHO to measure adherence include pill counts, pharmacy refill rec-
ords, and self-reporting [34].
What was found
A systematic review identified 50 studies to assess the comparative diagnostic accuracy of dif-
ferent adherence measures, including pill counts, pharmacy refill records, and self-reporting
[35]. Overall, the review found that all adherence measures had low sensitivity for identifying
people who are nonadherent and have unsuppressed viral loads.
Future research
Composite adherence measures, such as combining self-report with pharmacy refill or tablet
count, appeared to have higher sensitivity. Research is encouraged to identify the most accu-
rate measures of adherence—alone or in combination—that are feasible in settings with lim-
ited resources as a complement to viral load testing. Specific population groups face additional
challenges to adherence, and these should be considered.
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Integration of HIV and sexual and reproductive health services
Background
Integration of services for different diseases that commonly affect the same person can lead to
improved uptake and outcomes associated with these services. In 2019, an estimated 1.1 billion
women of reproductive age needed family planning, and, of these, 270 million had an unmet
need for contraception. Across regions, sex workers have a greater unmet need for contracep-
tion than the general population, and there are reports of excessive reliance on using condoms
alone instead of the recommended dual protection [36–39]. WHO emphasizes the importance
of linking sexual and reproductive health and rights and HIV for adolescent girls and young
women [40].
What was found
A systematic review published in 2019 found that the proportion of women receiving an HIV
test during the study period ranged from 35% to 99% for integrated services and from 20% to
95% for nonintegrated services or services integrated at a lower level [41]. The proportion of
women accessing HIV services using contraception ranged from 54% to 80% for integrated
services and from 10% to 83% for nonintegrated services [41]. The review included 6 studies—
1 cluster randomized trial carried out in Uganda and 5 nonrandomized cluster trials carried
out in Kenya, Eswatini, and the USA. The overall certainty of evidence for all outcomes was
very low. Another systematic review of 14 studies found that integrating family planning into
HIV care and treatment settings was associated with higher levels of use and knowledge of
modern methods of contraception among women living with HIV [42].
Future research
Research is encouraged to identify approaches to integration that lead to better uptake of sex-
ual and reproductive health services, including contraception; such research should also con-
sider integrating cervical cancer screening and vaccination. Implementation research is
encouraged to evaluate different strategies of integration in different health systems and social
contexts, including providing contraception in the context of less frequent clinical and ART
refill visits.
Integration of HIV and diabetes and hypertension care
Background
According to WHO, 15 million people 30 to 69 years old die prematurely from noncommunic-
able diseases every year, and 85% of these people live in low- and middle-income countries.
Diabetes and hypertension are the major cardiovascular risk factors for target organ damage of
the brain, heart, and kidneys. An estimated 425 million people in low- and middle-income
countries currently have diabetes. The prevalence of hypertension among adults in low- and
middle-income countries is estimated to exceed 20% [43]. With continued adherence to treat-
ment, people living with HIV can expect a near-normal life expectancy [44] and an increased
risk of noncommunicable diseases (especially cardiovascular diseases, cervical cancer, depres-
sion, and diabetes) related to HIV itself and to ART-related side effects [45,46].
What was found
The systematic review identified 2 interrupted time series studies [47,48] and 3 cluster ran-
domized trials [49–51]; 4 studies were carried out in sub-Saharan Africa, and 1 was carried out
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in India. These studies found that integrated models of care that include hypertension or dia-
betes or multidisease approaches may increase the number of people controlling both blood
pressure and HIV. The overall certainty of evidence was very low, and the available evidence is
limited [52].
Future research
The following research gaps were identified: long-term data on the health outcomes of people
living with HIV who have noncommunicable diseases, cost-effectiveness data for various mod-
els of integrated care, and implementation research on optimizing the supply chain. Research
can help to define health promotion activities that encourage lifestyle changes and protect
against noncommunicable diseases among people living with HIV who may face stigma and
other challenges to receiving health promotion through the usual channels. Research is also
needed to inform how hypertension and diabetes care can be integrated with the common dif-
ferentiated models of HIV service delivery. Qualitative research can inform the values and
preferences of people living with HIV and noncommunicable diseases related to how care is
delivered.
Psychosocial interventions for adolescents and young adults
Background
Adolescents and young adults living with HIV face distinct challenges as they navigate the
healthcare system, take on responsibilities of managing their own care and treatment, and con-
front issues relating to stigma and disclosure [53]. These challenges include numerous mental
and social issues, including depression, stigma, isolation, difficulties with treatment adherence
and retention, sexual risk-taking practices, and substance use [54].
What was found
A systematic review identified 30 randomized controlled trials of psychosocial interventions
for adolescents and young adults [55]; most studies were carried out in the USA (18 studies) or
sub-Saharan Africa (9 studies). Psychosocial interventions improved adherence to ART and
increased the proportion of individuals with viral suppression.
Future research
Additional research is required to identify interventions that improve outcomes for different
groups of adolescents and young adults living with HIV, including those with disabilities,
mental health conditions, those who acquired HIV perinatally versus horizontally, younger
adolescents, those out of school, orphans, ethnic minority groups, key populations, those who
are pregnant, and those living in contexts of adversity such as extreme poverty and humanitar-
ian emergencies. Research is also needed to assess the effectiveness of delivery strategies that
involve parents and caregivers for both younger and older adolescents.
Further research is needed to inform feasible and effective training, supervision, and imple-
mentation of support models at scale for facilitators of psychosocial interventions, including
peer providers. Intervention studies should include methods to report costs. Studies are
encouraged to use standardized outcome definitions to enhance the comparability of findings.
Lastly, follow-up beyond the immediate postintervention period is needed to understand the
long-term impact of psychosocial interventions.
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Task sharing of specimen collection and point-of-care testing
Background
Access to diagnostic testing and sample collection remains low in many resource-limited set-
tings, partly because of shortages of human resources, especially in rural settings. The lack of
skilled laboratory professionals at healthcare facilities may require the involvement of lower
cadres of healthcare workers.
What was found
The systematic review identified 65 studies that assessed the diagnostic accuracy of point-of-
care testing when performed by nonlaboratory personnel [56]. Most studies (86%) were car-
ried out in Africa. The certainty of the evidence was rated as moderate. DAU : PleasenotethatasperPLOSstyle; italicsshouldnotbeusedforemphasis:iagnostic accuracy
was found to be similar for point-of-care CD4, early infant diagnosis, cryptococcal antigen lat-
eral flow assays, syphilis testing, and several laboratory markers when these tests were per-
formed by nonlaboratory personnel. For viral load testing, point-of-care viral load testing
reduced turnaround time of results to clinicians.
Future research
Additional diagnostic accuracy studies directly comparing the performance of newer point-of-
care technologies infant diagnosis and viral load testing between nonlaboratory personnel and
laboratory professionals would be valuable.
Discussion
The HIV response has progressively evolved with clear direction coming from the science of
HIV service delivery.
This article summarizes research questions that were established through a WHO guideline
development process to make a series of recommendations to improve HIV service delivery in
2021.
The identification of research questions through the guideline development process has the
advantage of being informed by updated systematic reviews of the subject area including an
assessment of the certainty of the evidence through the GRADE process and interpretation by
a diverse group of experts representing all WHO regions, including implementers and end
users. Such an approach is restricted to the particular challenges addressed by the guideline.
Other related guidelines developed by WHO in 2021 include screening and treatment to pre-
vent cervical cancer [57] and the management of sexually transmitted infections [58]; these
guidelines include research gaps to improve the management of these challenges. Another lim-
itation to note is that research questions identified through guideline development reflect the
views of those individuals who comprised the guideline development group and cannot be
taken to represent the full spectrum of research gaps that exist within HIV service delivery
research. Other approaches have been used by WHO to identify research priorities include
expert consultation alone, literature reviews, multicriterion decision analysis, interviews, sur-
veys, Child Health and Nutrition Research Initiative (CAU : PleasenotethatCHNRIhasbeendefinedasChildHealthandNutritionResearchInitiativeinthesentenceOtherapproacheshavebeenused::::Pleasecheckandcorrectifnecessary:HNRI), Delphi, and ouncil on H alth
Research for Development (CAU : PleasenotethatCOHREDhasbeendefinedasCouncilonHealthResearchforDevelopmentinthesentenceOtherapproacheshavebeenused::::Pleasecheckandcorrectifnecessary:OHRED) 3D [59]. I can be anticipat d that the applicati of 1
or more of these approaches would have identified different research priorities (such as the
impact of pharmacy stockouts on adherence and viral suppression).
During the initial response to the Coronavirus Disease 2019 (COVID-19) pandemic, a
number of rapid adaptions to service delivery were made to ensure continuity of essential
health services [60]. It will be important to ensure that beneficial health service adaptions
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implemented in response to an emergency situation and are known to improve outcomes—for
example, extended ART refills and community dispensing—are formally integrated into rou-
tine care, and the effects of novel service delivery adaptions are evaluated.
While evidence from randomized and observational study designs has made an important
contribution—answering questions related to, for example, task sharing [61] and decentraliza-
tion of ART initiation [62]—implementation science is playing an increasingly important role,
helping answer questions about why effective interventions are not reaching the people who
could benefit from them and how health system failures can prevent the scale up of quality ser-
vices [63].
As service delivery evolves, it is important to ensure that improvements align with the lives
of recipients of care to decrease the direct and indirect costs associated with seeking and
receiving healthcare. A person-centered approach to delivering HIV services will be critical to
bringing countries closer to achieving the target of ending AIDS as a public health threat and
situating HIV treatment and care as part of universal healthcare coverage.
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